Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.3%

339 terminated/withdrawn out of 2760 trials

Success Rate

83.2%

-3.3% vs industry average

Late-Stage Pipeline

11%

311 trials in Phase 3/4

Results Transparency

39%

648 of 1681 completed trials have results

Key Signals

367 recruiting648 with results211 terminated128 withdrawn

Enrollment Performance

Analytics

N/A

1373(61.9%)

Phase 2

264(11.9%)

Phase 1

234(10.5%)

Phase 4

221(10.0%)

Phase 3

90(4.1%)

Early Phase 1

37(1.7%)

2219Total

N/A(1373)

Phase 2(264)

Phase 1(234)

Phase 4(221)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2760)

Showing 20 of 2760 trials

NCT06171139Not ApplicableRecruiting

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

Role: lead

NCT06975033Not ApplicableRecruiting

Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP

Role: lead

NCT07502339Phase 4Not Yet Recruiting

Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis

Role: lead

NCT06323824Phase 4Recruiting

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Role: collaborator

NCT04754269Not ApplicableCompleted

A Mobile Health Intervention to Reduce Sweet Beverage Consumption in Latino Children

Role: lead

NCT07534098Not ApplicableNot Yet Recruiting

Intervention for Hearing Health Among Native Americans

Role: lead

NCT06398509Not ApplicableRecruiting

A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children

Role: lead

NCT06854198Not ApplicableRecruiting

Glaucoma Screening to Enhance At-Risk Californians' Health

Role: lead

NCT07397117Not ApplicableRecruiting

Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care

Role: lead

NCT04197596Phase 1Recruiting

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Role: collaborator

NCT05057702Not ApplicableRecruiting

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

Role: lead

NCT05979389Phase 1Recruiting

Bicalutamide Therapy in Young Women With NAFLD and PCOS

Role: lead

NCT06449521Not ApplicableActive Not Recruiting

BECOME COmbined Intervention for MH & NCD Delivered by Community Health Workers in Nepal

Role: collaborator

NCT03828201Phase 2Active Not Recruiting

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Role: collaborator

NCT06834867Not ApplicableRecruiting

Multi-component Family Intervention to Lower Depression and Address Intimate Partner Violence in Nepal

Role: collaborator

NCT06183281Not ApplicableRecruiting

Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity

Role: lead

NCT05837949Not ApplicableActive Not Recruiting

Multiple Sclerosis Falls Insight Track

Role: lead

NCT04148625Enrolling By Invitation

Subxyphoid Hybrid MAZE Registry for Patients With Persistent Atrial Fibrillation

Role: lead

NCT07223099Not ApplicableNot Yet Recruiting

Sauna for Offline Connections and Interactive, Authentic Living

Role: lead

NCT07041931Active Not Recruiting

Empowering Newcomer Voices: A Trauma-Informed, Gender-Responsive Group Intervention in Schools (VOCES-NUEVAS)

Role: lead